Investigating the effect of Vitamin E on the elevated Liver Transaminase levels induced by Atorvastatin Use
Not Applicable
- Conditions
- iver Transaminase elevation.nonspecific elevation of Transaminase and Lactic Acid Dehydrogenase
- Registration Number
- IRCT2014042817470N1
- Lead Sponsor
- Vice Chancellor for Medical Sciences research of Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 23
Inclusion Criteria
l Patients with elevated Liver Transaminase levels induced by Atorvastatin Use at level of 1.5 to 3 times more than its baseline levels.
Exclusion criteria:Patients who had received other medications with effect on elevation of Liver Transaminase levels;patients who had history of Liver disease or elevated Liver Transaminase levels before Atorvastatin use.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method iver Transaminases. Timepoint: One week befor intervention and one day after intervention. Method of measurement: Unit in dl.
- Secondary Outcome Measures
Name Time Method Vomiting,Neusea. Timepoint: Two weeks after intervention. Method of measurement: yes or no.